Stock Option

LigaChem Biosciences Inc.

141080·KOSDAQ·46 grants

Shares granted, cumulative
1,491,360shares
Next lockup release
D-221
2027-03-29

Against the share price

At the 2026-08-18 close
KRW
-7.73%
Shares with a reason to exercise
903,110 shares
2.44% of shares outstanding
Sellable right now
800,610 shares
89% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩54.5B

Potential dilution

2.64%Against the 15% cap

Shares by strike price

  • ₩198,4007K shares
  • ₩105,20067K shares
  • ₩105,100Latest price
  • ₩72,80093K shares
  • ₩68,10010K shares
  • ₩55,9005K shares
  • ₩47,650215K shares
  • ₩47,50060K shares
  • ₩46,1005K shares
  • ₩44,90073K shares
  • ₩36,350444K shares

Below the line (strike < Latest price) sits above the strike price: 903K shares, 92% of the shares still inside their exercise window.

Exercise deadline within a yearD-12Earliest deadline 2026-09-01

The paper gain on 352,520 shares sitting above the strike price — ₩20.4B — disappears unless they are exercised by the deadline. Among the options whose lockup has ended, this is the part whose timing is pinned down.

See every approaching deadline

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩105,1002025-08-14 ~ 2026-08-18
  • Strike ₩36,350444K sharesabove
  • Strike ₩47,650215K sharesabove
  • Strike ₩72,80093K sharesabove
  • Strike ₩44,90073K sharesabove

Recipients by role

1.7MShares granted
  • Registered director5 people4%
  • Unregistered officer254 people39%
  • Employee191 people16%
  • Other · unknown274 people42%

Sorted from the relation text written in the filings (724 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.

Shares granted by year

41K
59K
117K
106K
70K
126K
352K
444K
103K
67K
7K
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26

Cumulative grants per recipient

5 named · 333 withheld
Largest holder채제욱Unregistered officer
Top holder 11.9%Top 3 22.4%
RecipientShares, cumulativePaper gain
116,05011.9%₩7.4B
52,7805.4%₩3.3B
50,0005.1%₩2.9B
28,6602.9%₩1.8B
5,0000.5%₩246M
724,94074.2%₩38.9B

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.